BioDiscovery Releases a Unique New Global Repository for Genomic Variation Data
February 22, 2010
El Segundo, CA - BioDiscovery, Inc. a leader in integrated software solutions for microarray-based research, announced today the release of Nexus DB a unique new repository for storing, querying, and sharing of genomic variation data from its popular Nexus Copy Number software. This novel repository addresses many of the high demand market requirements. Namely, it provides a secure off-site storage to ensure 24/7 access to all data being generated with automated backup and versioning control. Next, it provides a means to query results across multiple projects allowing users to build on their previous or related work. Finally, it facilitates collaborative work by making it easy to access and review data from anywhere in the world by any group of users. Built on the Amazon Web Services infrastructure platform, Nexus DB runs on Amazon Elastic Compute Cloud (EC2) with the data stored in Amazon Simple Storage Service (S3). Extensive security features are implemented to easily provide secure individual and group level access.
“Nexus DB is a unique addition to version 5 of Nexus Copy Number software. Not only is it a repository for secure off-site redundant storage of Nexus projects but it is also a tool for easily querying many datasets simultaneously” said Dr. Soheil Shams, President of BioDiscovery, Inc. “We are responding to the needs of institutions and consortiums looking for tools to cultivate collaborative work and Nexus DB does that and more. It allows users to enhance their dataset by querying for specific aberrations or phenotypes within results from the growing community-contributed data. We feel these new features will be a huge asset to labs and consortia looking to pool data from across the globe. The repository already contains data from several publications, The Cancer Genome Atlas project, large datasets of 'normal' samples, autism samples and much more.”
Nexus DB is an off-site repository for redundant back up of data from projects created within BioDiscovery’s Nexus Copy Number software. Nexus DB is easily accessed from within the Nexus Copy Number client application with secure password protected login from individual user accounts. Various consortia and special interest groups can be easily formed within Nexus DB to limit access to certain data to members of specific groups.
About BioDiscovery, Inc.
BioDiscovery is a leader in the development of advanced microarray bioinformatics software and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. Contact BioDiscovery: 310-414-8100 or www.biodiscovery.com